ロード中...
Acute Cerebral Infarction Following Intravenous Glycoprotein IIb/IIIa Inhibitor for Acute Myocardial Infarction
Stroke is a rare but serious complication of acute myocardial infarction (AMI). Currently, glycoprotein (GP) IIb/IIIa inhibitor is used in clinical practice for acute coronary syndromes and percutaneous coronary interventions (PCIs). The incidence of stroke in patients receiving GP IIb/IIIa inhibito...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Society of Cardiology
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3193047/ https://ncbi.nlm.nih.gov/pubmed/22022331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4070/kcj.2011.41.9.546 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|